What is Global Pruritus Drugs Market?
The Global Pruritus Drugs Market is a segment of the pharmaceutical industry that focuses on the development, production, and distribution of medications designed to alleviate pruritus, or itching. This market is a crucial component of the broader healthcare sector, as pruritus can be a symptom of various underlying health conditions, including dermatological diseases, systemic illnesses, and psychological disorders. The drugs in this market work by targeting the specific causes of pruritus, providing relief to patients and improving their quality of life. These medications come in various forms, including creams, ointments, lotions, pills, and injections, and are sold through various channels, including hospitals, pharmacies, and online platforms. The Global Pruritus Drugs Market is driven by various factors, including the rising prevalence of diseases that cause pruritus, advancements in medical research and drug development, and increasing awareness about the availability and effectiveness of these drugs.
Topical, Oral, Parenteral in the Global Pruritus Drugs Market:
The Global Pruritus Drugs Market is segmented based on the type of medication, including Topical, Oral, and Parenteral. Topical drugs are applied directly to the skin and are typically used for localized pruritus. They include creams, ointments, and lotions that contain active ingredients like corticosteroids, antihistamines, and local anesthetics. Oral drugs are taken by mouth and are usually used for systemic or widespread pruritus. They include antihistamines, corticosteroids, and antidepressants. Parenteral drugs are administered through injections or infusions and are typically used for severe or refractory pruritus. They include opioid antagonists, immunosuppressants, and biologic agents. The choice of medication depends on various factors, including the cause and severity of pruritus, the patient's overall health status, and the potential side effects of the drugs.
Hematologic Pruritus, Oncological Pruritus, Renal Pruritus, Endocrine Pruritus, Cholestatic Pruritus in the Global Pruritus Drugs Market:
The Global Pruritus Drugs Market caters to various areas of healthcare, including Hematologic Pruritus, Oncological Pruritus, Renal Pruritus, Endocrine Pruritus, and Cholestatic Pruritus. Hematologic Pruritus is associated with blood disorders like polycythemia vera and lymphoma. Oncological Pruritus is related to cancer and its treatments. Renal Pruritus is linked to kidney diseases, particularly chronic kidney disease and dialysis. Endocrine Pruritus is associated with hormonal disorders like hyperthyroidism and diabetes. Cholestatic Pruritus is related to liver diseases that cause bile accumulation, such as primary biliary cirrhosis and hepatitis. The drugs in this market are designed to target the specific causes of pruritus in these areas, providing effective relief to patients and improving their overall health outcomes.
Global Pruritus Drugs Market Outlook:
Looking at the market outlook, the global pharmaceutical market is projected to reach a value of 1475 billion USD in 2022, growing at a compound annual growth rate (CAGR) of 5% over the next six years. This growth is driven by various factors, including the increasing prevalence of chronic diseases, advancements in medical research and drug development, and the rising demand for effective and safe medications. In contrast, the chemical drug market is expected to grow from 1005 billion USD in 2018 to 1094 billion USD in 2022. This growth is fueled by the ongoing innovations in chemical drug synthesis and formulation, the expanding applications of chemical drugs in various areas of healthcare, and the increasing investments in chemical drug research and development.
Report Metric | Details |
Report Name | Pruritus Drugs Market |
CAGR | 5% |
Segment by Type |
|
Segment by Application |
|
By Region |
|
By Company | Allergan Plc, Astellas Pharma Inc., GlaxoSmithKline Plc, Pfizer Inc., Sanofi |
Forecast units | USD million in value |
Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |